Cargando…
A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol
BACKGROUND: Corifollitropin alfa, a fusion protein lacking LH activity, has a longer elimination half-life and extended time to peak levels than recombinant FSH (rFSH). A single injection of corifollitropin alfa may replace seven daily gonadotrophin injections during the first week of ovarian stimul...
Autores principales: | Devroey, P., Boostanfar, R., Koper, N.P., Mannaerts, B.M.J.L., IJzerman-Boon, P.C., Fauser, B.C.J.M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2777786/ https://www.ncbi.nlm.nih.gov/pubmed/19684043 http://dx.doi.org/10.1093/humrep/dep291 |
Ejemplares similares
-
Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol
por: Griesinger, Georg, et al.
Publicado: (2016) -
Repeated ovarian stimulation with corifollitropin alfa in patients in a GnRH antagonist protocol: no concern for immunogenicity
por: Norman, Robert J., et al.
Publicado: (2011) -
The role of corifollitropin alfa in controlled ovarian stimulation for IVF in combination with GnRH antagonist
por: Seyhan, Ayse, et al.
Publicado: (2011) -
A new approach for ovarian stimulation in IVF using Corifollitropin Alfa in combination with GnRH analogues to trigger final oocyte maturation. A pilot study
por: Decleer, W., et al.
Publicado: (2014) -
Corifollitropin alfa compared to daily rFSH or HP-HMG in GnRH
antagonist controlled ovarian stimulation protocol for patients undergoing
assisted reproduction
por: Souza, Priscila Morais Galvão, et al.
Publicado: (2017)